Clinical Trial Update: Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating subcutaneous C.E.R.A. (methoxy polyethylene glycol-epoetin beta) in pre-dialysis patients with anemia of chronic kidney disease has t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• C.E.R.A. (methoxy polyethylene glycol-epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: TERMINATED | Results posted: 2016-05-27